查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1541256

2024-2032 年按藥物類別、產品類型、治療類型、給藥途徑和地區分類的氣喘治療市場報告

Asthma Therapeutics Market Report by Drug Class, Product Type, Treatment Type, Route of Administration, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 141 Pages | 商品交期: 2-3個工作天內

價格

IMARC Group年，全球氣喘治療市場規模達到 180 億美元。

氣喘治療藥物是指用於治療氣喘的各種藥物。氣喘通常由室內和室外致病因素引發，包括污染、過敏原和灰塵。這些治療藥物通常是支氣管擴張劑和抗發炎藥，包括皮質類固醇、長效BETA受體激動劑（LABA）、甲基黃嘌呤、免疫調節劑和白三烯調節劑。也使用許多可以吸入、注射或口服給藥的合併治療藥物。這些藥物可擴張進入肺部的通道，使空氣流動以改善呼吸。它們還有助於清除肺部的黏液，從而輕鬆咳出。

氣喘治療市場趨勢：

氣喘和其他呼吸系統疾病的盛行率不斷上升，以及診斷技術的改進，是推動市場成長的關鍵因素之一。此外，大眾對有效氣喘治療方法的認知不斷提高也推動了市場的成長。例如，氣喘患者主要使用吸入性皮質類固醇進行治療，晚期或持續性氣喘患者則使用針對特定目標的藥物進行治療。對阻斷免疫球蛋白 E 和特定細胞因子的單株抗體 (mAb) 也有廣泛的需求。用於治療呼吸系統疾病的聯合療法的發展是另一個生長誘導因素。醫療保健支出的增加、醫學領域廣泛的研究和開發（R＆D）活動以及醫療保健基礎設施的改善是預計進一步推動市場的其他因素。

本報告回答的關鍵問題

  • 2023 年全球氣喘治療市場規模有多大？ 2024-2032年全球氣喘治療市場的預期成長率是多少？
  • 推動全球氣喘治療市場的關鍵因素是什麼？
  • COVID-19 對全球氣喘治療市場有何影響？
  • 根據藥物類別，全球氣喘治療市場的細分如何？
  • 根據產品類型，全球氣喘治療市場的細分如何？
  • 根據治療類型，全球氣喘治療市場的細分如何？
  • 根據給藥途徑，全球氣喘治療市場的細分如何？
  • 全球氣喘治療市場的關鍵地區有哪些？
  • 誰是全球氣喘治療市場的主要參與者/公司？

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 數據來源
    • 主要來源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球氣喘治療市場

  • 市場概況
  • 市場表現
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：依藥物類別

  • 抗發炎藥
    • 市場趨勢
    • 市場預測
  • 支氣管擴張劑
    • 市場趨勢
    • 市場預測
  • 聯合療法
    • 市場趨勢
    • 市場預測

第 7 章：市場區隔：依產品類型

  • 吸入器
    • 市場趨勢
    • 主要類型
      • 乾粉吸入器
      • 定量吸入器
      • 軟霧吸入器
    • 市場預測
  • 霧化器
    • 市場趨勢
    • 主要類型
      • 氣動霧化器
      • 超音波霧化器
      • 網狀霧化器
    • 市場預測

第 8 章：市場區隔：依治療類型

  • 快速緩解藥物
    • 市場趨勢
    • 市場預測
  • 長期氣喘控制藥物
    • 市場趨勢
    • 市場預測

第 9 章：市場區隔：依管理途徑

  • 吸入
    • 市場趨勢
    • 市場預測
  • 口服
    • 市場趨勢
    • 市場預測
  • 注射用
    • 市場趨勢
    • 市場預測

第 10 章：市場區隔：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場趨勢
    • 市場細分：按國家/地區
    • 市場預測

第 11 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 12 章：價值鏈分析

第 13 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 14 章：價格分析

第15章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • AstraZeneca PLC
    • Abbott Laboratories
    • Amgen Inc.
    • Biogen Inc.
    • Boehringer Ingelheim International GmbH
    • F. Hoffmann-La Roche Ltd.
    • GlaxoSmithKline Plc
    • Merck Sharp & Dohme Corp.
    • Novartis International AG
    • Sunovion Pharmaceuticals Inc.
    • Teva Pharmaceutical Industries Ltd.
Product Code: SR112024A2338

The global asthma therapeutics market size reached US$ 18 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 22.0 Billion by 2032, exhibiting a growth rate (CAGR) of 1.9% during 2024-2032.

Asthma therapeutics refer to various pharmaceutical drugs that are used for the treatment of asthma. Asthma is usually triggered by indoor and outdoor causative agents, including pollution, allergens and dust. These therapeutics are usually bronchodilators and anti-inflammatory drugs, which include corticosteroids, long-acting beta-agonists (LABA), methylxanthine, immunomodulators and leukotriene modifiers. A number of combination therapy drugs are also used that can be inhaled, injected, or orally administered. These drugs expand the passageway into the lungs and enable the movement of air to improve breathing. They also aid in clearing mucus from the lungs that gets coughed out with ease.

Asthma Therapeutics Market Trends:

The increasing prevalence of asthma and other respiratory disorders, along with improvements in the diagnostic technologies, is one of the key factors driving the growth of the market. Furthermore, rising awareness among the masses regarding the availability of effective asthma therapeutics is also providing driving the market growth. For instance, asthmatic patients are primarily treated with inhaled corticosteroids and patients with advanced conditions or persistent asthma are treated with target-specific drugs. There is also an extensive demand for monoclonal antibodies (mAbs) that block immunoglobulin E and specific cytokines. The development of combination therapies for the treatment of respiratory diseases is acting as another growth-inducing factor. Increasing healthcare expenditures, extensive research, and development (R&D) activities in the field of medical sciences and improvements in the healthcare infrastructure are some of the other factors that are expected to drive the market further.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global asthma therapeutics market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on drug class, product type, treatment type and route of administration.

Breakup by Drug Class:

Anti-Inflammatory Drugs

Bronchodilators

Combination Therapies

Breakup by Product Type:

Inhalers

Dry Powder Inhalers

Metered Dose Inhalers

Soft Mist Inhalers

Nebulizers

Pneumatic Nebulizers

Ultrasonic Nebulizers

Mesh Nebulizers

Breakup by Treatment Type:

Quick-Relief Medications

Long-Term Asthma Control Medications

Breakup by Route of Administration:

Inhalation

Oral

Parenteral

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being AstraZeneca PLC, Abbott Laboratories, Amgen Inc., Biogen Inc., Boehringer Ingelheim International GmbH, F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Merck Sharp & Dohme Corp., Novartis International AG, Sunovion Pharmaceuticals Inc. and Teva Pharmaceutical Industries Ltd.

Key Questions Answered in This Report

  • 1. What was the size of the global asthma therapeutics market in 2023?
  • 2. What is the expected growth rate of the global asthma therapeutics market during 2024-2032?
  • 3. What are the key factors driving the global asthma therapeutics market?
  • 4. What has been the impact of COVID-19 on the global asthma therapeutics market?
  • 5. What is the breakup of the global asthma therapeutics market based on the drug class?
  • 6. What is the breakup of the global asthma therapeutics market based on the product type?
  • 7. What is the breakup of the global asthma therapeutics market based on the treatment type?
  • 8. What is the breakup of the global asthma therapeutics market based on the route of administration?
  • 9. What are the key regions in the global asthma therapeutics market?
  • 10. Who are the key players/companies in the global asthma therapeutics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Asthma Therapeutics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Drug Class

  • 6.1 Anti-Inflammatory Drugs
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Bronchodilators
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Combination Therapies
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Product Type

  • 7.1 Inhalers
    • 7.1.1 Market Trends
    • 7.1.2 Major Types
      • 7.1.2.1 Dry Powder Inhalers
      • 7.1.2.2 Metered Dose Inhalers
      • 7.1.2.3 Soft Mist Inhalers
    • 7.1.3 Market Forecast
  • 7.2 Nebulizers
    • 7.2.1 Market Trends
    • 7.2.2 Major Types
      • 7.2.2.1 Pneumatic Nebulizers
      • 7.2.2.2 Ultrasonic Nebulizers
      • 7.2.2.3 Mesh Nebulizers
    • 7.2.3 Market Forecast

8 Market Breakup by Treatment Type

  • 8.1 Quick-Relief Medications
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Long-Term Asthma Control Medications
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Route of Administration

  • 9.1 Inhalation
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Oral
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Parenteral
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 AstraZeneca PLC
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Abbott Laboratories
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Amgen Inc.
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Biogen Inc.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Boehringer Ingelheim International GmbH
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 F. Hoffmann-La Roche Ltd.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 SWOT Analysis
    • 15.3.7 GlaxoSmithKline Plc
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Merck Sharp & Dohme Corp.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Novartis International AG
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Sunovion Pharmaceuticals Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 SWOT Analysis
    • 15.3.11 Teva Pharmaceutical Industries Ltd.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Asthma Therapeutics Market: Major Drivers and Challenges
  • Figure 2: Global: Asthma Therapeutics Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Asthma Therapeutics Market: Breakup by Drug Class (in %), 2023
  • Figure 4: Global: Asthma Therapeutics Market: Breakup by Product Type (in %), 2023
  • Figure 5: Global: Asthma Therapeutics Market: Breakup by Treatment Type (in %), 2023
  • Figure 6: Global: Asthma Therapeutics Market: Breakup by Route of Administration (in %), 2023
  • Figure 7: Global: Asthma Therapeutics Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Asthma Therapeutics Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 9: Global: Asthma Therapeutics (Anti-Inflammatory Drugs) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Asthma Therapeutics (Anti-Inflammatory Drugs) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Asthma Therapeutics (Bronchodilators) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Asthma Therapeutics (Bronchodilators) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Asthma Therapeutics (Combination Therapies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Asthma Therapeutics (Combination Therapies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Asthma Therapeutics (Inhalers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Asthma Therapeutics (Inhalers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Asthma Therapeutics (Nebulizers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Asthma Therapeutics (Nebulizers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Asthma Therapeutics (Quick-Relief Medications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Asthma Therapeutics (Quick-Relief Medications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Asthma Therapeutics (Long-Term Asthma Control Medications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Asthma Therapeutics (Long-Term Asthma Control Medications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Asthma Therapeutics (Inhalation) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Asthma Therapeutics (Inhalation) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Asthma Therapeutics (Oral) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Asthma Therapeutics (Oral) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Asthma Therapeutics (Parenteral) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Asthma Therapeutics (Parenteral) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: North America: Asthma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: North America: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: United States: Asthma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: United States: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Canada: Asthma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Canada: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Asia Pacific: Asthma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Asia Pacific: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: China: Asthma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: China: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Japan: Asthma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Japan: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: India: Asthma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: India: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: South Korea: Asthma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: South Korea: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: Australia: Asthma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: Australia: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Indonesia: Asthma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Indonesia: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Others: Asthma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Others: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: Europe: Asthma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: Europe: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Germany: Asthma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Germany: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: France: Asthma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: France: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: United Kingdom: Asthma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: United Kingdom: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Italy: Asthma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Italy: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Spain: Asthma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Spain: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Russia: Asthma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Russia: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Others: Asthma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Others: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Latin America: Asthma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Latin America: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Brazil: Asthma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Brazil: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Mexico: Asthma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Mexico: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Others: Asthma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Others: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Middle East and Africa: Asthma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Middle East and Africa: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Global: Asthma Therapeutics Industry: SWOT Analysis
  • Figure 78: Global: Asthma Therapeutics Industry: Value Chain Analysis
  • Figure 79: Global: Asthma Therapeutics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Asthma Therapeutics Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Asthma Therapeutics Market Forecast: Breakup by Drug Class (in Million US$), 2024-2032
  • Table 3: Global: Asthma Therapeutics Market Forecast: Breakup by Product Type (in Million US$), 2024-2032
  • Table 4: Global: Asthma Therapeutics Market Forecast: Breakup by Treatment Type (in Million US$), 2024-2032
  • Table 5: Global: Asthma Therapeutics Market Forecast: Breakup by Route of Administration (in Million US$), 2024-2032
  • Table 6: Global: Asthma Therapeutics Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Asthma Therapeutics Market Structure
  • Table 8: Global: Asthma Therapeutics Market: Key Players